Stephana Eilene Patton - Net Worth and Insider Trading
Stephana Eilene Patton Net Worth
The estimated net worth of Stephana Eilene Patton is at least $7,956 dollars as of 2024-09-20. Stephana Eilene Patton is the General Counsel of Lineage Cell Therapeutics Inc and owns about 7,500 shares of Lineage Cell Therapeutics Inc (LCTX) stock worth over $6,825. Stephana Eilene Patton is also the See Remarks of Eiger BioPharmaceuticals Inc and owns about 133 shares of Eiger BioPharmaceuticals Inc (EIGRQ) stock worth over $1,131. Details can be seen in Stephana Eilene Patton's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stephana Eilene Patton has not made any transactions after 2019-04-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Stephana Eilene Patton
Stephana Eilene Patton Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephana Eilene Patton owns 2 companies in total, including Eiger BioPharmaceuticals Inc (EIGRQ) , and Lineage Cell Therapeutics Inc (LCTX) .
Click here to see the complete history of Stephana Eilene Patton’s form 4 insider trades.
Insider Ownership Summary of Stephana Eilene Patton
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EIGRQ | Eiger BioPharmaceuticals Inc | 2019-04-22 | See Remarks |
| LCTX | Lineage Cell Therapeutics Inc | 2017-08-21 | General Counsel |
Stephana Eilene Patton Latest Holdings Summary
Stephana Eilene Patton currently owns a total of 2 stocks. Among these stocks, Stephana Eilene Patton owns 7,500 shares of Lineage Cell Therapeutics Inc (LCTX) as of August 21, 2017, with a value of $6,825 and a weighting of 85.79%. Stephana Eilene Patton also owns 133 shares of Eiger BioPharmaceuticals Inc (EIGRQ) as of April 22, 2019, with a value of $1,131 and a weighting of 14.21%.
Latest Holdings of Stephana Eilene Patton
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LCTX | Lineage Cell Therapeutics Inc | 2017-08-21 | 7,500 | 0.91 | 6,825 |
| EIGRQ | Eiger BioPharmaceuticals Inc | 2019-04-22 | 133 | 8.50 | 1,131 |
Holding Weightings of Stephana Eilene Patton
Stephana Eilene Patton Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephana Eilene Patton has made a total of 0 transactions in Lineage Cell Therapeutics Inc (LCTX) over the past 5 years. The most-recent trade in Lineage Cell Therapeutics Inc is the acquisition of 7,500 shares on August 21, 2017, which cost Stephana Eilene Patton around $19,350.
According to the SEC Form 4 filings, Stephana Eilene Patton has made a total of 0 transactions in Eiger BioPharmaceuticals Inc (EIGRQ) over the past 5 years. The most-recent trade in Eiger BioPharmaceuticals Inc is the acquisition of 33 shares on April 22, 2019, which cost Stephana Eilene Patton around $11,030.
Insider Trading History of Stephana Eilene Patton
- 1
Stephana Eilene Patton Trading Performance
GuruFocus tracks the stock performance after each of Stephana Eilene Patton's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephana Eilene Patton is -0.42%. GuruFocus also compares Stephana Eilene Patton's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephana Eilene Patton within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stephana Eilene Patton's insider trading performs compared to the benchmark.
Performance of Stephana Eilene Patton
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.34 | | | | | |
| Relative Return to S&P 500(%) | 6.74 | | | | | |
Stephana Eilene Patton Ownership Network
Stephana Eilene Patton Owned Company Details
What does Eiger BioPharmaceuticals Inc do?
Who are the key executives at Eiger BioPharmaceuticals Inc?
Stephana Eilene Patton is the See Remarks of Eiger BioPharmaceuticals Inc. Other key executives at Eiger BioPharmaceuticals Inc include 10 percent owner Richard A Kayne , 10 percent owner Leen Kawas , and Chief Business Officer Ingrid Choong .
Eiger BioPharmaceuticals Inc (EIGRQ) Insider Trades Summary
Over the past 18 months, Stephana Eilene Patton made no insider transaction in Eiger BioPharmaceuticals Inc (EIGRQ). Other recent insider transactions involving Eiger BioPharmaceuticals Inc (EIGRQ) include a net purchase of 278,239 shares made by Richard A Kayne , and a net purchase of 24,332 shares made by Leen Kawas .
In summary, during the past 3 months, insiders sold 0 shares of Eiger BioPharmaceuticals Inc (EIGRQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eiger BioPharmaceuticals Inc (EIGRQ) were sold and 10,086 shares were bought by its insiders, resulting in a net purchase of 10,086 shares.
Eiger BioPharmaceuticals Inc (EIGRQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eiger BioPharmaceuticals Inc Insider Transactions
Stephana Eilene Patton Mailing Address
Above is the net worth, insider trading, and ownership report for Stephana Eilene Patton. You might contact Stephana Eilene Patton via mailing address: 1010 Atlantic Avenue, Alameda Ca 94501.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
